Town of Patterson, New York - September 14, 2026 - PRESSADVANTAGE - Golden Group International, Ltd. has issued ...
The cross-border impact of smoke events reminds multinational corporations that severe air pollution can significantly disrupt normal operations indefinitely. With wisdom and foresight, organizations ...
Britain remains one of the safest countries in the world to work, but the level of risk faced by workers varies dramatically depending on ...
New metal paste and powder-based 3D printing technologies enable plastic injection molders to achieve faster cycle times and ...
SHELTON, CT / ACCESS Newswire / September 15, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
A new, tuition-free program from Youth Ottawa and Willis College – with funding from the Ontario government via Employment ...
While 3M has underperformed relative to the Dow over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.
The case involving Abhayrab, India's most widely used rabies vaccines, highlights how the illicit pharmaceutical trade is now ...
Traces of polychlorinated biphenyls were found on AN/PRM-10 test oscillator kits at F.E. Warren Air Force Base, home to 150 ...
Supporting ethical and domestic manufacturing boosts the availability of skilled jobs, indie labels and the wider economy ...
Giant Ojosama anime revealed its first teaser trailer and full cast on September 3, 2026, with Tatsunoko Production setting a ...
NanoViricides announces Phase II clinical trial registration for NV-387 oral gummies to treat Ebola in the Democratic Republic of Congo amid the largest outbreak.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results